These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32941783)

  • 21. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.
    Dash P; Turuk J; Behera SK; Palo SK; Raghav SK; Ghosh A; Sabat J; Rath S; Subhadra S; Rana K; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Dash S; Parida A; Pati S
    Int J Infect Dis; 2021 Mar; 104():491-500. PubMed ID: 33450373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atomistic insight into the essential binding event of ACE2-derived peptides to the SARS-CoV-2 spike protein.
    Sarto C; Florez-Rueda S; Arrar M; Hackenberger CPR; Lauster D; Di Lella S
    Biol Chem; 2022 Apr; 403(5-6):615-624. PubMed ID: 35357791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
    Dehury B; Raina V; Misra N; Suar M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7231-7245. PubMed ID: 32762417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.
    Sitthiyotha T; Chunsrivirot S
    Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of Specific Receptor Binding Mode Suggests a Possible Enzymatic Disinfectant for SARS-CoV-2.
    Cao Y; Ge J
    Langmuir; 2021 Feb; 37(5):1707-1713. PubMed ID: 33512172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.
    Jena AB; Kanungo N; Nayak V; Chainy GBN; Dandapat J
    Sci Rep; 2021 Jan; 11(1):2043. PubMed ID: 33479401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
    Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
    Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering.
    Mesias VSD; Zhu H; Tang X; Dai X; Guo Y; Liu W; Huang J
    Chem Commun (Camb); 2021 Jul; 57(57):6979-6982. PubMed ID: 34190246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
    Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
    J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2.
    Peng C; Zhu Z; Shi Y; Wang X; Mu K; Yang Y; Zhang X; Xu Z; Zhu W
    J Phys Chem Lett; 2020 Dec; 11(24):10482-10488. PubMed ID: 33274945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biomaterial polyphosphate blocks stoichiometric binding of the SARS-CoV-2 S-protein to the cellular ACE2 receptor.
    Müller WEG; Neufurth M; Schepler H; Wang S; Tolba E; Schröder HC; Wang X
    Biomater Sci; 2020 Dec; 8(23):6603-6610. PubMed ID: 33231598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
    Luan B; Wang H; Huynh T
    FEBS Lett; 2021 May; 595(10):1454-1461. PubMed ID: 33728680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2.
    Prajapat M; Shekhar N; Sarma P; Avti P; Singh S; Kaur H; Bhattacharyya A; Kumar S; Sharma S; Prakash A; Medhi B
    J Mol Graph Model; 2020 Dec; 101():107716. PubMed ID: 32866780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.
    Acharya A; Lynch DL; Pavlova A; Pang YT; Gumbart JC
    Chem Commun (Camb); 2021 Jun; 57(48):5949-5952. PubMed ID: 34019602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
    Basit A; Ali T; Rehman SU
    J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensin-converting enzyme 2 binding.
    Yesudhas D; Srivastava A; Sekijima M; Gromiha MM
    Proteins; 2021 Sep; 89(9):1158-1166. PubMed ID: 33893649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
    Jafary F; Jafari S; Ganjalikhany MR
    Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors.
    Rodriguez JH; Gupta A
    Sci Rep; 2021 Jan; 11(1):1156. PubMed ID: 33441985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants.
    Sang P; Chen YQ; Liu MT; Wang YT; Yue T; Li Y; Yin YR; Yang LQ
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.